ISHARES TR - ISHARES BIOTECH (IBB)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / ISHARES BIOTECH
Symbol
IBB
Price per share
$168.77
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
32,004,004
Holdings value
$4,624,774,830
% of all portfolios
0.01%
Share change
-521,334
Value change
-$68,100,454
Average buys %
+0%
Average sells %
-0%
Number of holders
792
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, ISHARES TR - ISHARES BIOTECH (IBB) has 792 institutional shareholders filing 13F forms. They hold 32,004,004 shares .

Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 335,367 $56,714,521 +$10,179,374 $168.77 39
2025 Q3 32,004,004 $4,624,774,830 -$68,100,454 $144.37 792
2025 Q2 31,072,085 $3,936,382,892 +$47,323,371 $126.51 788
2025 Q1 31,021,201 $3,972,426,635 -$396,140,166 $127.90 823
2024 Q4 34,631,693 $4,587,175,558 +$20,421,833 $132.21 863
2024 Q3 35,359,061 $5,149,559,679 -$572,938,906 $145.60 890
2024 Q2 38,415,167 $5,275,249,504 +$1,492,177 $137.26 888
2024 Q1 38,620,890 $5,298,106,513 +$323,414,616 $137.22 892
2023 Q4 19,834 $2,694,436 +$892,633 $135.85 9
2023 Q3 38,501,580 $4,708,254,943 -$193,364,356 $122.29 817
2023 Q2 40,186,069 $5,102,483,402 -$181,183,267 $126.96 821
2023 Q1 39,280,962 $5,073,747,201 -$571,695,986 $129.16 842
2022 Q4 43,299,548 $5,683,596,624 +$657,483,349 $131.29 883
2022 Q3 38,960,462 $4,558,254,743 -$62,468,037 $116.96 807
2022 Q2 39,758,495 $4,677,892,876 -$141,169,961 $117.63 835
2022 Q1 41,114,998 $5,360,627,985 -$31,418,759 $130.30 867
2021 Q4 40,816,921 $6,223,611,410 -$360,852,761 $152.62 939
2021 Q3 43,045,363 $6,958,174,469 -$482,882,743 $161.68 836
2021 Q2 45,959,265 $7,520,410,587 -$738,435,392 $163.65 846
2021 Q1 50,846,313 $7,654,159,188 -$1,312,016,169 $150.56 828
2020 Q4 58,423,437 $8,853,809,639 +$1,019,573,818 $151.49 832
2020 Q3 54,473,189 $7,372,812,850 -$452,912,932 $135.41 766
2020 Q2 57,587,489 $7,872,404,278 +$1,165,791,083 $136.69 751
2020 Q1 46,989,332 $5,064,977,691 -$724,888,730 $107.74 652
2019 Q4 53,147,242 $6,403,282,435 -$7,824,764 $120.51 697
2019 Q3 52,755,099 $5,250,612,391 -$6,275,737 $99.50 586
2019 Q2 51,860,599 $5,654,793,545 +$176,235,725 $109.10 643
2019 Q1 49,714,617 $5,557,318,660 +$248,431,833 $111.80 660
2018 Q4 47,716,968 $4,602,865,798 -$270,760,497 $96.43 639
2018 Q3 51,623,930 $6,293,643,751 -$537,690,723 $121.94 626
2018 Q2 55,868,199 $6,136,858,703 +$254,558,815 $109.82 602
2018 Q1 53,099,773 $5,667,350,832 -$16,793,760 $106.74 603
2017 Q4 53,436,877 $5,706,891,998 +$3,314,034,037 $106.77 616
2017 Q3 19,322,648 $6,443,789,945 +$611,584,608 $333.59 577
2017 Q2 17,591,741 $5,456,089,468 +$99,391,312 $310.08 556
2017 Q1 17,205,255 $5,045,615,118 +$495,951,098 $293.27 517
2016 Q4 15,579,946 $4,132,936,658 -$147,053,762 $265.38 518
2016 Q3 16,084,873 $4,615,878,833 +$577,303,465 $289.46 457
2016 Q2 14,518,997 $3,728,804,326 -$163,189,433 $257.34 420
2016 Q1 14,818,013 $3,855,048,469 -$448,532,321 $260.81 408
2015 Q4 16,460,391 $5,547,563,096 -$1,682,919,480 $338.33 426
2015 Q3 21,164,352 $6,422,553,089 +$1,097,574,632 $303.33 406
2015 Q2 17,917,908 $6,609,367,034 -$267,830,891 $368.97 415
2015 Q1 18,652,504 $6,405,375,888 +$719,078,060 $343.43 391
2014 Q4 16,777,167 $5,089,540,479 -$691,229,269 $303.35 364
2014 Q3 18,941,267 $5,181,473,893 +$604,670,120 $273.63 312
2014 Q2 16,695,187 $4,290,857,456 -$590,317,087 $257.03 300
2014 Q1 19,090,905 $4,512,539,004 +$1,286,111,391 $236.40 287